Vizion 2020
Withdrawn from the US market on 10 May 2016 (according to the DSLD)
Good 'N Natural, food supplement from the US market
Label withdrawn from the US market. Vizion 2020 (Good 'N Natural), a food supplement au code-barres 698138690158, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. Doses of vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Good 'N Natural
- Barcode
- 698138690158
- Form
- Tablet
- One serving
- 1 tablet
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Vegetable Cellulose, Silica, Vegetable Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin A | Vitamin | 2,500 UI |
| Vitamin C | Vitamin | 50 mg |
| Vitamin E | Vitamin | 50 UI |
| L-Taurine | Other substance | 300 mg |
| Schisandra (Schisandra chinensis) | Plant | 80 mg |
| Quercetin | Other substance | 75 mg |
| Bilberry | Plant | 65 mg |
| N-Acetyl Cysteine | Other substance | 65 mg |
| Bayberry (Myrica cerifera) | Plant | 50 mg |
| Carrot | Plant | 50 mg |
| Eyebright | Plant | 50 mg |
| Ginkgo biloba | Plant | 50 mg |
| L-Glutamic Acid | Amino acid | 30 mg |
| L-Glycine | Amino acid | 30 mg |
| Kale (Brassica oleracea) | Plant | 25 mg |
| Mustard | Plant | 25 mg |
| Passion Flower (Passiflora incarnata) | Plant | 25 mg |
| Turnip | Plant | 25 mg |
| L-Glutathione | Other substance | 12.5 mg |
| Alpha Lipoic Acid | Other substance | 5 mg |
| Tomato concentrate | Plant | 2.4 mg |
| Lycopene | Other substance | 30 µg |
| Coenzyme Q-10 | Other substance | 2.5 mg |
| Vinpocetine | Other substance | 2 mg |
| Lutein | Other substance | 0.39 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Vizion 2020
Entered into DSLD on 25 June 2012. Withdrawn from the US market on 5 February 2016 (according to the DSLD).Same active composition.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Passion Flower
Read the warning, when it applies and the studies cited
PASSIONFLOWER -PASSIFLORA INCARNATA
Route of administration: Oral
Cautions and warnings
Condition of application: Sleep aid.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Berardi et al. 2002: DiPiro et al. 2002).
Sources cited by Health Canada (2)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
Condition of application: Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product avoid taking with alcohol or products that cause drowsiness (EMA 2014; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2014).
Sources cited by Health Canada (1)
- EMA 2014. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 20 September 2016. [Accessed 2023 October 1]. Available from: https://www.ema.europa.eu/documents/herbal-summary/passion-flower-summary-public_en.pdf
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Good 'N Natural
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Vizion 2020 : étiquette retirée du marché américain (Good 'N Natural): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/698138690158-vizion-2020-good-n-natural, updated 10 May 2016.